Which has grown faster, PGNY or URGN?

Over the past five years, URGN grew revenue faster — PGNY at a 23.84% CAGR versus URGN at 42.66%.

Is PGNY or URGN more profitable?

PGNY runs the higher net margin — PGNY at 6.00% versus URGN at -51.73%.

How have PGNY and URGN total returns compared?

Over the past 5 years, PGNY delivered -14.83% and URGN delivered 20.32% annualized total return. Past performance doesn't predict future results.

Progyny, Inc. (PGNY) vs UroGen Pharma Ltd. (URGN)

A side-by-side comparison of Progyny, Inc. and UroGen Pharma Ltd. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

PGNY

Progyny, Inc.

$2.03B

$25.91HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT

URGN

UroGen Pharma Ltd.

$2.02B

$41.43HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT

Total return — PGNY vs URGN

growth of $100 · dividends reinvested · last 7y

PGNY +62.2% (+7.2%/yr)URGN +94.7% (+10.0%/yr)URGN compounded faster over this window

PGNY URGN

PGNY vs URGN: by the numbers

•PGNY is the larger company ($2.03B vs $2.02B market cap).
•PGNY is profitable (6.00% net margin) while URGN runs a net loss (-51.73%).
•URGN grew revenue faster over the past five years (42.66% vs 23.84% CAGR).

Metrics side by side

Valuation

Metric	PGNY	URGN
P/E ratio	28.16	N/A
Forward P/E	20.15	N/A
PEG ratio	4.20	N/A
P/S ratio	1.55	10.70
P/B ratio	4.48	N/A
EV / EBITDA	15.95	N/A
FCF yield	10.74%	N/A

Profitability

Metric	PGNY	URGN
Gross margin	24.57%	90.85%
Operating margin	8.55%	-113.73%
Net margin	6.00%	-51.73%
ROE	17.35%	N/A
ROIC	15.47%	-34.96%

Growth (annualized)

Metric	PGNY	URGN
Revenue CAGR (5Y)	23.84%	42.66%
EPS CAGR (5Y)	4.72%	N/A
FCF CAGR (5Y)	73.48%	N/A
Total return CAGR (5Y)	-14.83%	20.32%

Frequently asked

Which has grown faster, PGNY or URGN?: Over the past five years, URGN grew revenue faster — PGNY at a 23.84% CAGR versus URGN at 42.66%.
Is PGNY or URGN more profitable?: PGNY runs the higher net margin — PGNY at 6.00% versus URGN at -51.73%.
How have PGNY and URGN total returns compared?: Over the past 5 years, PGNY delivered -14.83% and URGN delivered 20.32% annualized total return. Past performance doesn't predict future results.

Go deeper

Full PGNY analysis Full URGN analysis Interactive comparison tool

Dig into the metrics

Progyny P/E ratio Progyny ROE UroGen Pharma ROE Progyny operating margin UroGen Pharma operating margin Progyny revenue growth UroGen Pharma revenue growth Progyny free cash flow UroGen Pharma free cash flow

Progyny & UroGen Pharma appear in these rankings

Fastest Revenue Growth Stocks Highest FCF Yield Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.